Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $5,339 | $27,701 | $90,657 | $77,311 |
| - Cash | $18,179 | $28,773 | $23,066 | $18,271 |
| + Debt | $25,082 | $25,859 | $25,396 | $25,576 |
| Enterprise Value | $12,242 | $24,788 | $92,987 | $84,616 |
| Revenue | $48,340 | $36,927 | $30,451 | $34,464 |
| % Growth | 30.9% | 21.3% | -11.6% | – |
| Gross Profit | $9,762 | $2,431 | $6,577 | $12,070 |
| % Margin | 20.2% | 6.6% | 21.6% | 35% |
| EBITDA | -$14,613 | -$21,074 | -$19,253 | -$861,006 |
| % Margin | -30.2% | -57.1% | -63.2% | -2,498.3% |
| Net Income | -$23,291 | -$33,904 | -$25,521 | -$13,675 |
| % Margin | -48.2% | -91.8% | -83.8% | -39.7% |
| EPS Diluted | -0.96 | -1.4 | -1.34 | -0.81 |
| % Growth | 31.4% | -4.5% | -65.4% | – |
| Operating Cash Flow | -$12,694 | -$30,886 | -$18,887 | -$9,056 |
| Capital Expenditures | -$1,451 | -$1,858 | -$4,167 | -$3,800 |
| Free Cash Flow | -$14,145 | -$32,743 | -$23,054 | -$12,855 |